HOME Research Insight New Product Launch and Product Upgradation was the Key Growth Strategy in the Virus Filtration Market between 2013 and 2015



New Product Launch and Product Upgradation was the Key Growth Strategy in the Virus Filtration Market between 2013 and 2015


Virus Filtrationís kits and reagents, filtration systems, other products and services are mainly used for applications including biologicals, medical devices, water purification, and air purification.

The global virus filtration market was dominated by Merck & Co., Inc. (U.S.), and General Electric Company (U.S.) in 2014. These two companies together accounted for a share of ~52% of the global virus filtration market in 2014. With its well established distribution network and broad product portfolio, Merck & Co., Inc. held the leadership position in the global virus filtration market in 2014. Merckís product portfolio includes a vast range of filters and single-use systems, comprising Viresolve Prefilter Pod Disposable Devices, Viresolve NFP Cartridge Filters etc. Over the past three years, the company adopted the strategy of new product launches and acquisitions to maintain its leadership position in the global virus filtration market.

General Electric Company (U.S.) held the second position in the virus filtration market in 2014. The company has strong geographical presence and robust product portfolio for several virus filtration applications such as biologicals, medical devices, water purification, and air purification. The company adopted agreements, collaborations and partnerships as its key business strategies to uphold its leading position in the global virus filtration market.

The major players in this market include Merck & Co., Inc. (U.S.), General Electric Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Lonza Group Ltd. (Switzerland), and Pall Corporation (U.S.), Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Sartorius AG (Germany), Asahi Kasei Medical Co., Ltd. (Japan) and WuXi PharmaTech (Cayman) Inc. (China).

In the virus filtration market, leading players are adopting the strategies of new product launches, product upgradation, expansions, agreements, and acquisitions to increase their presence. New product launches and agreements, collaborations and partnerships together accounted for 64.4% of the overall growth strategies adopted by market players.

The other important growth strategy adopted by players in this market is mergers & acquisitions. This strategy was adopted by the players market to enhance their product portfolio by acquiring a potential player in this market. These strategies were adopted by major players in this market such as Merck & Co., Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Pall Corporation (U.S.), Charles River Laboratories International, Inc. (U.S.), and WuXi PharmaTech (Cayman) Inc. (China), between 2013 and 2015.

Related Reports:

Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports